Pavilion Publishing and Media Ltd
Blue Sky Offices Shoreham, 25 Cecil Pashley Way, Shoreham-by-Sea, West Sussex, BN43 5FF, UNITED KINGDOM
Tel: +44 (0)1273 434 943
Email: [email protected]
The All Wales Medicines Strategy Group (AWMSG) has recommended Trulicity (dulaglutide once weekly injection) for adults with type 2 diabetes mellitus, pharma Eli Lilly has announced. More than 180,000 people in Wales currently live with diabetes, with a further 70,000 people living with undiagnosed type 2 diabetes. Dulaglutide is licenced for the treatment of adults with type 2 mellitus to improve glyxaemic control in combination with other medication, including insulin, when other options including in conjunction with exercise and diet, have failed to work. The decision means dulaglutide will now be available for restricted use in Wales as an alternative
---------------------------
This content is restricted to members of Pavilion Health Today. If you are an existing user, please log in. New users may register for free below.